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Conserved sequencesel transcriptional regulatory elements, microarray cotransfection was used to
functionally characterize conserved non-coding sequences (CNSs) of three immediate early genes: c-fos, JunB
and EGR-1. Cotransfection of ﬂuorescent CNS reporter constructs and expression vectors for constitutively
active signaling proteins demonstrated that many of the CNSs alter both the basal and regulated expressions
of reporter constructs, but the effects of these CNSs were usually speciﬁc for their homologous promoter. One
CNS located in the ﬁrst intron of the c-fos gene conferred regulation by cAMP-dependent protein kinase
(PKA), cGMP-dependent protein kinase (PKG) and Raf. Mutagenesis and cotransfection experiments showed
that PKA regulation of this c-fos intronic element was mediated by two adjacent CRE-like sequences and the
transcription factor CREB. In the context of a reporter containing previously characterized regulatory
elements, the novel intronic sequence contributed 50% of the transcriptional response to PKA. These studies
suggest that microarray transfection studies may be useful in functional characterization of conserved
genomic sequences on a larger scale.
© 2008 Elsevier Inc. All rights reserved.IntroductionAnalyses of the human and other mammalian genomes show that
5% of the human genome has evolved under signiﬁcant evolutionary
constraint, but only a third of these sequences can be assigned to
protein-coding regions [1]. A detailed understanding of the potential
role these conserved non-coding sequences (CNSs) play in transcrip-
tional regulation in vivo remains a major goal for the ﬁeld of functional
genomics [2]. However, this effort is hampered by our limited global
understanding of transcription factor (TF) function. Since experimen-
tal determinations of TF binding speciﬁcity are incomplete, bioinfor-
matic approaches relying on this information can be inaccurate [3,4].
For example, bioinformatic and experimental approaches have
identiﬁed 1500 human genes with cognate cAMP response element
(CRE) sequences for the well-studied TF, cyclic AMP response element
binding protein (CREB1), however less than 2% of these genes actually
respond transcriptionally to cAMP elevation [5]. The mechanisms
responsible for this higher order speciﬁcity are not well understood,
but are likely to involve chromatin modiﬁcations such as histone
methylation or acetylation [6,7].
The transcriptional regulation of the immediate early genes (IEGs)
is well studied, in part because this regulation results from theNeuroscience Institute, 5043
Arbor, MI 48109-2200, USA.
l rights reserved.activation of pre-existing transcription factors and does not require
protein synthesis [8,9]. The tissue speciﬁc expression of IEGs from the
c-fos, Jun and Krox protein families is thought to participate
differentially in the tissue-speciﬁc transcriptional responses of multi-
ple cell types. Transcription of IEGs is rapidly and transiently increased
in response to growth factor activation of the mitogen-activated
protein kinase pathway as well as the cAMP and cGMP pathways.
Transfection of cells in a microarray format has been used to
characterize the in vivo functional role of individual proteins using
siRNA and cotransfection of signaling proteins [10,11]. However, this
strategy has not been previously applied to screen for functional cis-
regulatory sequences. We have described a solid phase cotransfection
method termed Surface Transfection and Expression Protocol (STEP)
that relies on the use of recombinant proteins to mediate the
cotransfection of multiple cell types, including neuronal cell lines
and neurons [12,13]. By combining STEP cotransfection with com-
parative genomic analysis, we show that many of the 22 CNSs
associated with 3 immediate early genes (c-fos (FOS), JunB (JUNB) and
EGR1) are regulated in a microarray transfection assay. We then
studied in detail a novel regulatory element within the ﬁrst intron of
the c-fos gene which contributes signiﬁcantly to regulation of the c-fos
gene by PKA, PKG and Raf.
Results
Using a functional genomic approach, we sought to determine if
microarray transfection could be used to identify sequences mediating
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in Fig.1, genomic sequences fromall 3 IEGs are rich in CNSs, particularly
in the region upstream of the transcriptional start site. Based on
sequence conservation among mammalian genomic sequences, CNSs
for each of these geneswere targeted for isolation by PCR ampliﬁcation
of genomic sequences (see Supplementary Table 1).
IEGs are transcriptionally regulated by intracellular signaling path-
ways which result in phosphorylation of many TFs. These signaling
pathways include the cAMP/PKA, cGMP/PKG and the Ras/MAPK path-
ways. We initially chose expression vectors for the Cα catalytic subunit
isoformof PKA (PRKACA) [14], the CAAXmutantof Raf-1 (RAF1) [15] and
the V12G mutant of the Ras protein [16] as co-transfected effector
proteins. We determined the ability of these three signaling proteins to
regulate CNS reporter activity in the microarray cotransfection assay.
Each of these three effector constructs was independently co-trans-
fected with one of the CNS-GFP reporter constructs by spotting STEP
complexes onto microscope slides and plating HEK-293T cells onto the
arrayed complexes. After 36 h the cellular EGFP ﬂuorescence was
determined by ﬂuorescence microscopy of individual spots or by ﬁxing
the cells and scanning the slides as described [12] (see Materials and
methods). A representative ﬂuorescence scan image of a ﬁxed slide is
shown in Fig. 2A, where regulation of the reporter EGFP ﬂuorescence by
the cotransfected effector vectors can be seen.Fig. 1. Identiﬁcation of highly conserved non-coding sequences (CNSs) within and adjacent to
upper panel shows the nucleotide sequence identity between the correspondingmouse and h
exonic regions which showmore than 75% conservation are located and marked with orange
with blue. The lower panel indicates the regions of CNSs and promoter used to construct repor
the control fragment (less than 60% conservation) are gray.As shown in Figs. 2B–D, quantitationof the cellularﬂuorescence 36h
after transfection demonstrated that the basal activity of the reporters
in the absence of co-transfectedproteinswas signiﬁcantly inﬂuencedby
the presence of individual CNSs. For the c-fos promoter, all of the CNSs
increased the basal activity of over the c-fos promoter alone, but the
U4U5 andU6 sequences increased the basal level bymore than an order
of magnitude. On the other hand, for the JunB and EGR1 promoters the
addition of CNSs often decreased basal activity. Cotransfectionwith the
constitutively active PKA expression vector increased transcription over
basal levels for the c-fosU3and I1 reporters (Fig. 2B). PKAcotransfection
typically had little effect on the transcription of the JunB CNS reporters,
although the D1 CNS sequence showed strong repression by PKA (Fig.
2C). PKA had a small stimulatory effect on the EGR1 promoter construct
as well as the various EGR1 CNS reporters, with the exception of the D2
CNS (Fig. 2D). The statistically signiﬁcant results from these experi-
ments at 36h following transfection are summarized inTable 1. PKAwas
found to positively regulate two c-fos CNS reporters (U3 and I1) but to
negatively regulate the JunB-D1 CNS reporter. Raf downregulated two
CNS reporters (cfos-U4U5 and JunB-U2U3) but stimulated the EGR1-
promoter. Since the EGR1 promoter showed regulation by Raf and Ras,
most of the CNS reporters derived from this promoter showed
regulation as well and statistically signiﬁcant from the basal promoter
was not found for most CNS reporters.the c-fos, JunB and EGR1 immediate early genes. For c-fos (A), JunB (B), and EGR1 (C) the
uman genomic sequences as analyzedbyVISTA(http://pipeline.lbl.gov). The CNSs outside
. The arrows above the graph indicates the transcribed sequences and exons are marked
ters in later Figs. The promoter fragments are indicated in green, the CNSs are orange, and
Fig. 2. The presence of CNSs determine regulation of IEG EGFP reporters by constitutively activated signaling proteins. (A) The ﬂuorescence of EGFP reporters in cells 48 h after
transfection is shown. Each small white rectangle indicates a set of four regions where a CNS reporter was co-transfected with one of four different expression vectors for
constitutively active signaling proteins. Each rectangle corresponds to a 1.7 mm×2.0 mm region of the microscope slide. The larger rectangle shows at a higher magniﬁcation the
cellular ﬂuorescence associated with cells transfected with the I1c-fos CNS reporter and the constitutively active signaling proteins (Ras, Raf and PKA). For the c-fos (B), JunB (C) and
EGR1 (D) reporters, the panels show representative STEP assay results in HEK-293T cells. The transfected DNA contained 90% of the indicated reporter plasmid and 5% of PKA, Ras or
Raf expression vector or the control vector. The STEP assay was performed as described in Materials and methods. For the results shown here, EGFP ﬂuorescence was monitored from
the living cells using ﬂuorescence microscopy. Cellular ﬂuorescence levels that show statistical signiﬁcant differences (pb0.05) from the corresponding control cotransfections are
indicated with an asterisk (⁎).
161X. Ren, M.D. Uhler / Genomics 93 (2009) 159–168
Table 1
Statistically signiﬁcant regulation of IEG CNS reporters
Reporter HEK 36 h HEK 48 h Neuro2A 60 h
cfos-pro – PKG(+9.5) Ras(+2.4)
cfos-U1U2 – PKG(+5.4) Ras(+3.2)
cfos-U3 PKA(+3.2) PKA(+2.8),
PKG(+1.9)
–
cfos-U4U5 Raf(−3.3), Ras(−3.0) PKG(+3.2),
Raf(−6.9)
–
cfos-U6 – – Raf(−1.5), Ras(−2.4)
cfos-I1 PKA(+3.7) PKA(+12.4),
PKG(+6.3)
PKA(+7.9),
PKG(+7.7), Ras(+4.9)
cfos-C2 – PKG(+3.4) PKA(+1.4), PKG(−1.8)
JunB-U2U3 Raf(−2.8), Ras(+1.8) nd nd
JunB-U4 Ras(+4.1) nd nd
JunB-D1 PKA(−2.4), Raf(−2.1),
Ras(+2.2)
nd nd
EGR1-pro Raf(+1.9), Ras(+1.7) nd nd
All interactions shown demonstrated pb0.05 for three independent experiments. The
numbers in parentheses indicate the average fold regulation observed. A dash (–)
indicates that no statistically signiﬁcant regulation was detected. nd indicates that the
experiments were not done.
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greatest diversity in response to cotransfection (Fig. 2B), we compared
the c-fos reporters in two different cell types: human Hek293T cells
and mouse Neuro2A neuroblastoma cells. These two cell types differFig. 3. Cell-type speciﬁc regulation of c-fos CNS sequences by ﬁve constitutively active signali
(A) and Neuro2A neuroblastoma cells is shown. In both cell types, DNA contains 90% of c-fos C
signaling protein or control vector (seeMaterials andmethods). At 48 or 60 h after transfectio
Cellular ﬂuorescence levels that show statistical signiﬁcant differences (pb0.05) from the csigniﬁcantly in cell signaling pathways and transcription factors [12].
Conservation of regulation in both these cells would correlate with
evolutionary conservation of transcriptional regulation between
mouse and human cells. Also, because at longer times following
transfection some reporters showed increased ﬂuorescence, we
incubated HEK-293T cells for 48 h and Neuro2A cells for 60 h before
ﬂuorescence quantitation. These experiments also included an
expression vector for an additional constitutively active signaling
protein, the S79D constitutively active mutant of type I PKG [14]. PKG
and PKA show similar in vitro substrate speciﬁcity, but have been
shown to differ in their in vivo regulation of gene transcription since
PKA readily enters the nucleus but PKG does not [14].
As shown in Fig. 3A, the general trends in promoter regulation in
HEK cells at a later 48 h time point were comparable to those seen at
36 h (Fig. 2B) although the basal activity of some of the reporters is
higher. In particular, the U3 and I1 reporters again showed show
signiﬁcant increases when co-transfected with PKA in HEK-293T cells
(Table 1). Surprisingly, while the minimal c-fos promoter again
showed only minor induction by PKA, it was more signiﬁcantly
induced by PKG.
In Neuro2A cells, the minimal c-fos promoter showed higher
induction by Raf and Ras than by PKG, and it was not induced by PKA.
Also, while the c-fos U3 and I1 constructs showed induction by PKA in
HEK cells, these constructs yielded different results in Neuro2A cells.
The c-fos U3 reporter was not induced by PKA in Neuro2A cells but theng proteins. EGFP cellular ﬂuorescence associated with STEP transfected HEK-293T cells
NS reporter plasmid and 10% of expression vector for the indicated constitutively active
n, EGFP ﬂuorescencewasmonitored from the living cells using ﬂuorescencemicroscopy.
orresponding control cotransfections are indicated with an asterisk (⁎).
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the CNS reporters (U1U2, U3, I1 and C2) showed a strong induction by
Ras (Table 1).
While many of these regulatory interactions need to be studied
further,we chose the c-fos I1 CNSwithin theﬁrst intronof the c-fosgene
for a more detailed characterization. In part, this choice was because
intronic elements have been characterized less often than extragenicFig. 4. Two cAMP response elements (CREs) within intron1 of the c-fos genemediate PKA-ind
deletions. Left: I1 and its 5′ and 3′ deletion. Right: the corresponding mutations (mutation
subcloned into an EGFP reporter plasmid containing the minimal c-fos promoter (see Materia
panel A. The transfected DNA contained 90% of reporter plasmid and 5% of expression vector a
ice cold methanol and ﬂuorescence was monitored using a ﬂuorescence slide scanner (refer
differences (pb0.05) from the corresponding control cotransfections are indicated with an
luciferase reporter activities relative to the RL-SV40 Renilla internal control are shown f
experiments, transfected DNA consisted of 5% reporters, 85% expression vectors, 5% pRL-SV40
cells to ensure that transfection efﬁciencies were comparable on a cellular level. Normalized
(pb0.05) from the corresponding control cotransfections are indicated with an asterisk (⁎).elements and also in part becausewe observed consistent regulation of
this element by both PKA and PKG in both HEK and Neuro2A cells.
Furthermore, this sequence is stringently conserved during evolution,
with some sequence elements more highly conserved between human
and mouse than c-fos coding sequences (see Fig. 1).
As shown in Fig. 4A, the c-fos I1 sequence is predicted to have three
conserved SP1 binding sites and two CRE-like sequences (seeuction of I1 reporter constructs. (A) Schematic structure of I1 and its 5′ progressive- or 3′
of both CRE) of the I1 related structure shown in left panel. All of the fragments were
ls and methods). (B) Normalized EGFP ﬂuorescence for the reporter constructs shown in
nd 5% pCMVDsRed-1 (internal control). At 40 h after transfection, slides were ﬁxed with
to Materials and methods). Cellular ﬂuorescence levels that show statistical signiﬁcant
asterisk (⁎). (C) Schematic structure of ﬁreﬂy luciferase reporter constructs. (D) Fireﬂy
or cells at 24 h after transfection in HEK-293T cells. For these solution transfection
and 5% EGFP-C1. EGFP expressionwas used for microscopic examination of transfected
luciferase (ﬁreﬂy divided by Renilla) levels that show statistical signiﬁcant differences
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within the I1 sequence (I1-D1 through 11-D6) and oriented these
mutants upstream of the basal c-fos promoter, outside of the normal I1
intronic context. Following STEP transfection (Fig. 4B), the D4 and D5
mutants which lacked either one or both of the CRE-like sequences
showed no statistically signiﬁcant regulation by PKA.
Because transcriptional regulation of the I1 element by PKA was
abolished in the D4 and D5 deletionmutants lacking one or both CREs,
these sequences were targeted for mutagenesis as shown in Fig. 4A.
The CRE sequences were scrambled and reintroduced to the I1
element constructs as described in the Materials and methods.
Mutation of the CREs nearly eliminated the ability of the I1 sequence
to respond to PKA cotransfection in the full-length I1 CNS, as well as in
all of the deletion mutants (Fig. 4B).
In order to characterize the I1 regulatory sequences in greater
detail, we constructed corresponding ﬁreﬂy luciferase reporters
containing the c-fos I1 CNS sequences as shown in Fig. 4C. When
transfected into HEK-293T cells by solution transfection, the I1-c-fos
luciferase reporter construct showed the same induction by PKA seen
previously with the I1-c-fos EGFP construct in the microarray
transfection assay (Fig. 4D). Furthermore, this induction required the
kinase activity of PKA because the induction was not seen with a
catalytically inactive form of PKA Cα containing a Lys72 to MetFig. 5. The two CRE-like sequences within intron 1 regulate a c-fos reporter construct. (A) S
indicated. (B) Relative luciferase activity of the reporters at 24 h following cotransfection w
luciferase). Left: Normalized luciferase assay data (ﬁreﬂy over Renilla) from HEK-293T c
Normalized luciferase activity of the reporters in which I1-c-fos promoter is immediately afte
the ﬁrst intron. F9 teratocarcinoma cells were transfected as described in Materials and m
transfection. Normalized luciferase levels that show statistically signiﬁcant differences (pb0.0
double asterisk (⁎⁎) indicates samples that show statistically signiﬁcant differences (pb0.05mutation (data not shown). The mutant I1 reporter construct inwhich
the two CRE sequences had been scrambled was signiﬁcantly reduced
in the ability to be regulated by PKA (pb0.05). The I1-c-fos luciferase
construct also showed regulation by PKG and Raf and this regulation
was reduced in the mutant I1 reporter. Finally, when cloned in the
reverse orientation, the I1 sequence still showed a regulation by PKA
albeit at signiﬁcantly lower levels than the forward orientation. Thus
the regulation of I1 function by PKA seen using the EGFP reporter was
also conﬁrmed using the ﬁreﬂy luciferase reporter.
Regulation of c-fos transcription is extremely complex and
regulatory interactions include a transcriptional pause site at the 5′
end of the ﬁrst intron [17,18]. Since the original characterization of
the I1 sequence using microarray transfection (Fig. 2) involved assay
of the I1 sequence outside of its intronic context, we sought to
determine whether the CRE sequences of I1 were functional when
present in their native intronic location. For this reason, we generated
a ﬁreﬂy luciferase reporter construct containing 1 kb of 5′ sequence
upstream of the c-fos transcription start site, the c-fos promoter, exon
1, intron 1 and a fragment of exon 2 (nucleotides −1050 to +1259
relative to the c-fos transcriptional start site — see Fig. 5A). This
construct produces a fusion protein containing the ﬁrst 56 amino
acids of the c-fos gene fused to the amino terminus of the ﬁreﬂy
luciferase gene and includes the c-fos U6 CNS. We also mutated the 2chematic structure of c-fos gene and reporter constructs with the location of the CREs
ith PKA, PKG and Raf expression vectors (normalized to the internal control of Renilla
ells. Right: Normalized luciferase assay data from Neuro2A neuroblastoma cells. (C)
r I1 or its mutants. (D) Normalized luciferase activity of the reporters with I1 located in
ethods. Renilla (RL-US2) and ﬁreﬂy luciferase activities were determined 24 h after
5) from the corresponding control cotransfections are indicatedwith an asterisk (⁎). The
) from the corresponding wildtype reporter construct.
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c-fos mut reporter.
Transfection of the 2.2 kb c-fos reporter into HEK cells demon-
strated that the basal expression level of p2.2kc-fosLuc is signiﬁcantly
higher than that of pI1c-fosLuc (50–200 fold higher — compare Figs.
5B and 4D). This higher efﬁciency for the 2.2kcfosLuc was observed
even within the same transfection experiment (data not shown). This
result might be expected since the 2.2 kb genomic fragment contains
many additional cis-regulatory elements in their native context as
compared the I1-c-fos reporter. As shown in Fig. 5B, PKA, PKG and Raf
all signiﬁcantly (pb0.05) regulated the 2.2 kb c-fos reporter. The
2.2 kb c-fos mut reporter in which the two CRE sequences were
mutated demonstrated that the ability to be regulated by all three
constitutively active signaling proteins was reduced when the
intronic CRE sites were mutated, although the regulation by PKA
was the only interaction that showed statistically signiﬁcant reduc-
tion when the CREs were mutated. Induction by PKA was reduced by
more than 50% in HEK-293T cells for the mutant reporter as
compared to the wildtype 2.2 kb c-fos reporter. Reductions in
regulation by PKG and Raf were more modest, 21% and 28%, but
still suggested a role for the CREs in regulation by those proteins.
Interestingly, when the reporter was transfected into Neuro2A cells,
PKA and PKG regulated expression of the wildtype reporter but Raf
did not. Mutation of the CREs reduced PKA regulation signiﬁcantly
(20% reduction) in Neuro2A cells but the mutation did not alter
regulation by PKG.
We next sought to determine whether the CREB protein and PKA
phosphorylation of CREB could mediate the regulation seen with the
I1 CRE sequences. For this purpose, we used the F9 teratocarcinoma
cells which do not express a functional CREB protein [19]. F9 cells
were transfected ﬁrst with the I1-c-fos construct (see Fig. 4C for
construct) to determine if the I1 sequence was functional in F9 cells.
As shown in Fig. 5C, PKA stimulated the I1-c-fos reporter when the
expression vector for the CREB protein was co-transfected. Further-
more, expression of a CREB mutant in which Ser133 was mutated to
Ala abrogated this response suggesting PKA phosphorylation of this
residue was required for the transcriptional regulation of I1 by PKA
(Fig. 5C). In a second set of experiments (Fig. 5D), we assayed the
2.2 kb c-fos reporter containing the I1 sequence within its intronic
context. PKA cotransfection with the CREB expression vector
increased transcription of this reporter two-fold and this induction
by PKA was reduced to 1.3 fold when the two I1 CRE sequences were
mutated. The majority of the PKA induction required Ser133
phosphorylation because the PKA induction was greatly reduced
when the Ser133Ala form of CREB was co-transfected with the 2.2 kb
c-fos reporter construct. These results strongly implicate CREB and
CREB phosphorylation by PKA in the regulation of c-fos transcription
by the I1 sequence.
Discussion
CNSs are commonly characterized using tissue-speciﬁc reporter
expression during embryonic development [2,20,21]. However, they
are less commonly characterized with respect to acute regulation by
speciﬁc signaling pathways. We had previously used STEP cotransfec-
tion to compare PKA regulation of well characterized CRE containing
reporters in different cell types and demonstrated that transcriptional
regulation could be detected in this microarray format [12]. In the
current study, we used STEP transfection to functionally characterize
CNSs for the c-fos, EGR1 and JunB IEGs.
Our microarray transfection results for these CNSs suggest that
many of these sequences functionally regulate the EGFP reporters
used in STEP transfection (Table 1). While many of the CNS sequences
caused increases in GFP expression, there was signiﬁcant repression
seen as well. Several of the repressive interactions were seen with
constitutive expression of Ras and Raf, both proteins signaling in theMAPK pathway. Ras has been shown to down-regulate the expression
of a number of genes [22] and one mechanism for this down-
regulation is the methylation of speciﬁc promoter sequences via
activation of the Dnmt methyl transferase.
In addition to the c-fos I1 intronic sequence characterized in detail
here, the c-fos U3 CNS was shown to be regulated by PKA in HEK cells
(Figs. 2A and 3A). The c-fos U3 CNS does not contain a CREB-like
sequence, so the mechanism of transcriptional regulation is likely to
be distinct from that of the I1 sequence. The c-fos U3 CNS does
however contain a putative C/EBPα binding and PKA has been shown
to alter C/EBPα activity at several distinct levels. In the case of the
glucose-6-phosphatase promoter, a distal C/EBPα binding site like
that in the c-fos U3 CNS has been shown to interact with a proximal
CREB-binding site like that in the c-fos promoter and this interaction is
regulated by PKA [23]. In Aplysia, a heterodimer between C/EBP and
CREB forms and PKA phosphorylation of a speciﬁc serine residue
enhances formation of this heterodimer [24].
The c-fos I1 CNSwas chosen for a detailed characterization because
intronic regulatory elements are not generally well understood. A
374 bp CNS within the second intron of the human nestin gene has
been demonstrated to be responsible neural progenitor cell expres-
sion during development [25,26]. Within the ﬁrst intron of the mouse
acetylcholinesterase gene, a CNS containing N-box elements which
bind the transcription factor GABP mediates the enhancement of
acetylcholinesterase expression following muscle contraction [27].
Two CNSs within the second intron of the human BRCA1 gene
contribute to transcription of that gene and the effects of these CNSs
are promoter speciﬁc [28], similar to the speciﬁcity shown for the c-fos
I1 sequence. Although mutation and deletion analysis demonstrated
the requirement of the CRE sequences within the c-fos I1 CNS for
regulation by PKA, deletion analysis of the I1 CNS also suggested a
cooperation between the more 5′ sequences containing predicted SP1
binding sites and the two CREs near the 3′ end of the gene. Since cAMP
has been shown to regulate SP1 element activity [29] it is possible that
at least some of PKA regulation occurs through the SP1 binding
sequences of the I1 element.
While PKG shares similar in vitro substrate speciﬁcity with PKA, in
vivo transcriptional regulation differs for these two kinases [14,30].
Our current results showed that these two kinases regulated many of
the same CNS reporters, but that they showed differences in efﬁcacy.
For example, PKA and PKG both showed induction of nearly all c-fos
CNS reporter constructs. However, PKA was more effective at
regulation of the I1and U3 CNS reporters while PKG was more
effective at regulation of the U1U2 and U4U5 reporters in HEK-293T
cells (Fig. 3A). Furthermore, in Neuro2A cells these two kinases were
equally effective at induction of the I1 c-fos reporter (Fig. 3B).
Regulation of the c-fos I1 reporter by both kinases was dependent
on the CREs in HEK-293Tcells (Figs. 4B and D). Regulation of the 2.2 kb
c-fos reporter by both PKA and PKG was dependent on intact CREs
within intron 1, but PKG regulation in the Neuro2A cells was
unaffected by mutation of the CREs suggesting that other regulatory
elements mediated PKG regulation of this construct in Neuro2A cells.
Previous studies have demonstrated the importance of the ﬁrst
intron to c-fos gene regulation. First, a transcriptional block sitewithin
the ﬁrst intron was characterized in murine macrophages [17] and
shown to be dependent on a 103 bp sequence motif that is not
contained in the I1 CNS used in these studies. This 103 bp sequence of
themouse c-fos intron shows lower sequence conservation than the I1
CNS [31]. More recently additional deletion studies suggested that this
transcriptional block was required for calcium-dependent resumption
of transcription, but deletions of intron 1 which abolished the calcium
regulation did not delete the CRE sequences mutated in the I1 CNS
sequence [18]. This ﬁrst intron of the c-fos gene has also been shown to
be essential for transcriptional regulation by EGF, TRH and glucose
[32,33]. The regulation by EGF is particularly of interest because our
experiments demonstrated that constitutively active Ras was capable
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by EGF.
Our initial goal was to test the feasibility of using microarray
transfection for the identiﬁcation of novel cis-regulatory elements
within CNSs. Our results suggest that such a strategy should identify
novel regulatory sequences, although there are certainly caveats to the
genome wide application of this strategy. First, the generation of a
complete set of CNS reporters would be very labor intensive, although
comparable to the effort required for currently existing RNAi libraries.
Furthermore, multiple cell types would be required for such a
functional genomic analysis of CNS sequences because functional
regulation requires the presence of speciﬁc transcription factor and in
their absence a “false negative” result would be obtained. However,
the results of such a STEP strategy could be compared with the results
of Chip on Chip or Chip-Seq assays to identify chromosomal sequences
to which speciﬁc transcription factors are bound. In addition, the
results of such a genome wide survey subject to the concern that the
transiently transfected reporter DNA is not subject to the same
chromatin level regulation as that for the endogenous genes so it is
likely that a signiﬁcant number of “false positive” regulatory
sequences may be identiﬁed.
In summary, these studies were initiated to determine whether an
unbiased high throughput screening method such as microarray
transfection could be employed to discover novel transcriptional
regulatory elements. Our results suggest that microarray cotransfec-
tion of CNS reporter constructs with expression vectors for constitu-
tively active signaling proteins can be used to characterize regulatory
interactions that are novel and signiﬁcant. Speciﬁcally, we obtained
evidence to suggest that a highly conserved intronic element within
the ﬁrst intron of the c-fos gene is a physiologically signiﬁcant
mechanism for PKA regulation of c-fos gene expression.
Materials and methods
CNS and promoter sequence identiﬁcation
Because they were the ﬁrst completed mammalian genomic
sequences, human and mouse genomic sequences were aligned
using the VISTA analysis program (http://pipeline.lbl.gov) ([34,35])
and the UCSC Genome Browser (http://genome.ucsc.edu) [36].
Sequences showing greater than 75% conservation over 200 bp within
10 kb of the transcriptional start sites were designated as CNSs and
identiﬁed for the human c-fos, JunB and EGR-1 genes (see Supple-
mentary Table 1). Promoter regions were identiﬁed using the
transcriptional start sites reported previously for the human c-fos
[37], JunB [38] and EGR1 [39] genes. Transcription factor binding sites
were predicted using the Transcription Element Search System (TESS)
[40] and DNA Binding Database (DBD) [4] resources.
PCR ampliﬁcation and EGFP reporter construction
Oligonucleotides used to amplify the CNSs and the three IEG gene
promoters are shown in Supplementary Table 2. Human genomic DNA
was used as DNA template (Clontech) and oligonucleotides were
obtained from Invitrogen. The c-fos promoter was inserted between
EcoRI and BamHI site of pEGFP-1 (Clontech) to generate ppc-fos-EGFP.
The CNSs of c-fos gene were then inserted between HindIII and EcoRI
sites of ppc-fos-EGFP. The EGR1 promoter was inserted into pEGFP-1
between EcoRI and AgeI sites to generate the plasmid ppEGR1-EGFP.
The CNSs of EGR1 were then inserted into the ppEGR1-EGFP between
the XhoI and EcoRI sites. Finally, the JunB promoter was inserted
between EcoRI and BamHI sites of pEGFP-1 to generate ppJunB-EGFP
and the CNSs of JunB were inserted into between HindIII and EcoRI
site of ppJunB-EGFP.
The oligonucleotides used to amplify the various 5′ deletions and
3′ deletion of the ﬁrst intron (designated I1) of c-fos as well as thereverse orientation I1 reporter are shown in Supplementary Table 3.
The mutations of the two CREs within I1 were introduced by site-
directed mutagenesis as described [14] using the oligonucleotides
whose sequences are available on request. The I1 and I1 mutant
sequence were used as DNA template to amplify 5′ progressive-
deletions. I1 mutants and 5′ deletions were inserted between HindIII
and EcoRI into ppc-fos-EGFP.
PCR ampliﬁcation and luciferase reporter construction
The oligonucleotides used to amplify a 2.2 kb fragment containing
the promoter, ﬁrst exon and ﬁrst intron of the c-fos gene are shown in
Supplementary Table 4. This 2.2 kb fragment and its mutants were
inserted into pTAL-luciferase (Clontech) between SacI and NcoI site.
These reporter constructs produce a spliced transcript that encodes a
fusion protein containing the ﬁrst 56 amino acids of the c-fos gene
fused to the amino terminus of the ﬁreﬂy luciferase gene. The c-fos
promoter region from ppc-fos-EGFP above was isolated as a SacI/
BamHI fragment and inserted into SacI/BglII digested pTAL-luciferase.
The I1 CNS and I1 mutant sequences along with c-fos promoter were
also isolated from corresponding EGFP reporter constructs as Sac/
BamHI fragments and inserted into pTal-lLuc between SacI and BglII
sites. All of the reporter constructs were veriﬁed by DNA sequencing
(University of Michigan DNA sequencing facility). Restriction enzymes
were obtained from New England Biolabs and the ligation reagents
were from Promega. The pRL-SV40 plasmid with the SV40 promoter
directing expression of the Renilla luciferase was used as in internal
standard in Hek293T and Neuro2A cell transfections. The pRL-US2
plasmid containing the Ubiquitin C promoter driving expression of the
Renilla luciferase was constructed by isolating the 1.3 kb BglII/XbaI
fragment of pUS2 (the gift of Dr. David Turner) and ligation into BglII/
NheI digested SV40RL (Promega).
Constitutively active signaling vectors and STEP transfection
The expression vectors for the Cα catalytic subunit of PKA [14], the
K72M kinase deﬁcient mutant of Cα [41], the S79Dmutant of the type
I PKG [14], the RasV12 mutant [16] and the RafCAAX mutant [15] have
been described previously. The CMV.Neo control expression vector has
also been described [42]. The STEP transfectionmethod was described
in detail previously [12]. Typically, 3 μl of total transfected plasmid
DNA at a concentration of 0.12 μg/ul was complexed with 3 μl
Lipofectamine 2000 (1 mg/ml, Invitrogen), 3 μl adenoviral penton
protein (0.02 mg/ml) and 1 μl 25% glycerol to form 10 μl of STEP
complex solution. As reported previously, the optimal percentage of
reporter construct was 90–95% of the total transfected DNA [12]. The
STEP complexes were then loaded into 384-well plates (Genetix,
Hampshire, United Kingdom) and printed onto poly-D-lysine coated
slides (Electron, Microscopy Science, Hatﬁeld, PA) using a Microgrid II
microarrayer (San Carlos, CA). Exponentially growing HEK-293T or
Neuro2A neuroblastoma cells were then plated onto the slides as
described [12] and transfection efﬁciencies were 50–80% as reported
previously [12]. Variability in ﬂuorescence signal from the HEK-293T
cells was largely due to detachment of the cells during ﬁxation and
handling. Cellular ﬂuorescence levels from HEK-293T cells were
typically 5–10 fold higher than Neuro2A cells. The ﬂuorescence signal
from living cells was monitored using an inverted Olympus IX70
ﬂuorescence microscope, an IIIix CCD image system and MicroCom-
puter Image Device software (Imaging Research, Inc., St Catherines,
Ontario, Canada). Slides were also ﬁxed in 100% methanol (at −20 °C)
and then scanned using a CCD camera scanner (Array Worx“e”;
Applied Precision, Issaquah, WA). Fluorescence intensity was then
determined and analyzed using Digital Genome software (Applied
Precision). Quantitative results obtained from ﬂuorescence micro-
scopy or slide scanning were comparable for all experiments shown
although ﬂuorescence microscopy was more sensitive.
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Human HEK-293T cells, and mouse Neuro2A neuroblastoma or F9
teratocarcinoma cells were cultured in DMEM containing 10% FCS in
24-well plates. Transfection was performed when cells reached 50%
conﬂuency. Cells had been serum starved in DMEM containing 1% FCS
for 12 h before transfection to reduce basal expression of the
reporters. Solution transfection was performed using Lipofectamine
2000 (Invitrogen) and followed the procedure recommended by the
manufacturer using 0.64 μg DNA and 4.8 μl of Lipofectamine 2000
(1 mg/ml) for each well. At 24 h after transfection, relative luciferase
activity was determined by using a dual luciferase reporter assay kit
(Promega) according to the manufacturer's recommendation, using
either a OPTOCOMP I luminometer (MGM INC, Hamdan, CT) or
Fluostar OPTIMA plate reader (BMG).
Statistical analysis
Results are expressed as the mean±SD or SE and results are
representative of at least three independent experiments. Statistical
signiﬁcancewas determined by two-tailed Student's t-test and a value
of pb0.05 was considered signiﬁcant.
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